Your browser doesn't support javascript.
loading
Modulation of IL-17 backbone dynamics reduces receptor affinity and reveals a new inhibitory mechanism.
Shaw, Daniel J; Waters, Lorna C; Strong, Sarah L; Schulze, Monika-Sarah E D; Greetham, Gregory M; Towrie, Mike; Parker, Anthony W; Prosser, Christine E; Henry, Alistair J; Lawson, Alastair D G; Carr, Mark D; Taylor, Richard J; Hunt, Neil T; Muskett, Frederick W.
Affiliation
  • Shaw DJ; Department of Chemistry and York Biomedical Research Institute, University of York Heslington York YO19 5DD UK neil.hunt@york.ac.uk.
  • Waters LC; Department of Molecular and Cell Biology/Leicester Institute of Structural and Chemical Biology, University of Leicester, University Road Leicester LE1 7RH UK fwm1@leicester.ac.uk.
  • Strong SL; Department of Molecular and Cell Biology/Leicester Institute of Structural and Chemical Biology, University of Leicester, University Road Leicester LE1 7RH UK fwm1@leicester.ac.uk.
  • Schulze MED; UCB Pharma UCB Biopharma UK 216 Bath Road Slough SL1 3WE UK.
  • Greetham GM; Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory Harwell Oxford Didcot Oxon OX11 0QX UK.
  • Towrie M; Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory Harwell Oxford Didcot Oxon OX11 0QX UK.
  • Parker AW; Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory Harwell Oxford Didcot Oxon OX11 0QX UK.
  • Prosser CE; UCB Pharma UCB Biopharma UK 216 Bath Road Slough SL1 3WE UK.
  • Henry AJ; UCB Pharma UCB Biopharma UK 216 Bath Road Slough SL1 3WE UK.
  • Lawson ADG; UCB Pharma UCB Biopharma UK 216 Bath Road Slough SL1 3WE UK.
  • Carr MD; Department of Molecular and Cell Biology/Leicester Institute of Structural and Chemical Biology, University of Leicester, University Road Leicester LE1 7RH UK fwm1@leicester.ac.uk.
  • Taylor RJ; UCB Pharma UCB Biopharma UK 216 Bath Road Slough SL1 3WE UK.
  • Hunt NT; Department of Chemistry and York Biomedical Research Institute, University of York Heslington York YO19 5DD UK neil.hunt@york.ac.uk.
  • Muskett FW; Department of Molecular and Cell Biology/Leicester Institute of Structural and Chemical Biology, University of Leicester, University Road Leicester LE1 7RH UK fwm1@leicester.ac.uk.
Chem Sci ; 14(27): 7524-7536, 2023 Jul 12.
Article in En | MEDLINE | ID: mdl-37449080
ABSTRACT
Knowledge of protein dynamics is fundamental to the understanding of biological processes, with NMR and 2D-IR spectroscopy being two of the principal methods for studying protein dynamics. Here, we combine these two methods to gain a new understanding of the complex mechanism of a cytokinereceptor interaction. The dynamic nature of many cytokines is now being recognised as a key property in the signalling mechanism. Interleukin-17s (IL-17) are proinflammatory cytokines which, if unregulated, are associated with serious autoimmune diseases such as psoriasis, and although there are several therapeutics on the market for these conditions, small molecule therapeutics remain elusive. Previous studies, exploiting crystallographic methods alone, have been unable to explain the dramatic differences in affinity observed between IL-17 dimers and their receptors, suggesting there are factors that cannot be fully explained by the analysis of static structures alone. Here, we show that the IL-17 family of cytokines have varying degrees of flexibility which directly correlates to their receptor affinities. Small molecule inhibitors of the cytokinereceptor interaction are usually thought to function by either causing steric clashes or structural changes. However, our results, supported by other biophysical methods, provide evidence for an alternate mechanism of inhibition, in which the small molecule rigidifies the protein, causing a reduction in receptor affinity. The results presented here indicate an induced fit model of cytokinereceptor binding, with the more flexible cytokines having a higher affinity. Our approach could be applied to other systems where the inhibition of a protein-protein interaction has proved intractable, for example due to the flat, featureless nature of the interface. Targeting allosteric sites which modulate protein dynamics, opens up new avenues for novel therapeutic development.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Chem Sci Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Chem Sci Year: 2023 Document type: Article